Dichloromethane → Ethyl 1-[5-[2-(ethylcarbamoylamino)-6-methoxy-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-methyl-piperidine-4-carboxylate
Reaction equation
Br[C:2]1[C:3]([O:17][CH3:18])=[CH:4][C:5]2[S:9][C:8]([NH:10][C:11]([NH:13][CH2:14][CH3:15])=[O:12])=[N:7][C:6]=2[CH:16]=1.[CH3:19][C:20]1([C:41]([O:43][CH2:44][CH3:45])=[O:42])[CH2:25][CH2:24][N:23]([C:26]2[N:31]=[CH:30][C:29](B3OC(C)(C)C(C)(C)O3)=[CH:28][N:27]=2)[CH2:22][CH2:21]1.C(Cl)Cl.C(=O)([O-])[O-].[Cs+].[Cs+]>O1CCOCC1.O.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[CH2:14]([NH:13][C:11]([NH:10][C:8]1[S:9][C:5]2[CH:4]=[C:3]([O:17][CH3:18])[C:2]([C:29]3[CH:28]=[N:27][C:26]([N:23]4[CH2:24][CH2:25][C:20]([CH3:19])([C:41]([O:43][CH2:44][CH3:45])=[O:42])[CH2:21][CH2:22]4)=[N:31][CH:30]=3)=[CH:16][C:6]=2[N:7]=1)=[O:12])[CH3:15]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 110 °C
Procedure
1-(5-Bromo-6-methoxy-1,3-benzothiazol-2-yl)-3-ethyl-urea (Intermediate 11) (200 mg, 66 mass %, 0.40 mmol), ethyl 4-methyl-1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]piperidine-4-carboxylate (crude, 638 mg, 47 mass %, 0.80 mmol) and Pd(dppf)Cl2.DCM (16 mg, 0.02 mmol) were dissolved in dioxane (7.5 mL) in a microwave vial and a solution of cesium carbonate (391 mg, 1.20 mmol) in water (2.5 mL) was added. The vial was capped, the mixture degassed and heated in the microwave at 110° C. for 30 minutes. The mixture was poured into water, extracted into EtOAc (4×20 mL) and the organic layers washed with brine, dried over Na2SO4 and concentrated to dryness in vacuo. A yellow solid was obtained and the mixture purified by chromatography, Biotage SP4, 12 g Si cartridge, 0-5% MeOH in DCM. The relevant fractions were combined to give a brown solid which was further purified by chromatography, Biotage SP4, 12 g Si cartridge, 50% EtOAc in hexane (isocratic) then the column flushed with EtOAc. The relevant fractions were combined to give Compound 191 as a white solid, 110 mg (55%). 1H NMR (MeCN-d3): δ 1.19 (3H, t, J=7.2 Hz), 1.26 (3H, s), 1.29 (3H, t, J=7.1 Hz), 1.49 (2H, ddd, J=14.0, 10.5 and 4.1 Hz), 2.14 (2H, m), 3.32 (4H, m), 3.87 (3H, s), 4.20 (2H, q, J=7.1 Hz), 4.37 (2H, dt, J=14.0 and 4.1 Hz), 6.16 (1H, br s), 7.51 (1H, s), 7.61 (1H, s), 8.55 (2H, s), 8.77 (1H, br s). MS: 499.12 [M+H]+.
Workup
- customThe vial was capped
- customthe mixture degassed
- additionThe mixture was poured into water
- extractionextracted into EtOAc (4×20 mL)
- washthe organic layers washed with brine
- dry with materialdried over Na2SO4
- concentrationconcentrated to dryness in vacuo
- customA yellow solid was obtained
- customthe mixture purified by chromatography, Biotage SP4, 12 g Si cartridge, 0-5% MeOH in DCM
- customto give a brown solid which
- customwas further purified by chromatography, Biotage SP4, 12 g Si cartridge, 50% EtOAc in hexane (isocratic)
- customthe column flushed with EtOAc
Sources & evidence
- ORD record
- ord-b89c4e9fdee54aa2b09e365a69de12de
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09181234B2
Reaction notes
Loading…